The JAK2 V617F mutation is rare in RARS but common in RARS-T.
Ceesay
M M
MM
Lea
N C
NC
Ingram
W
W
Westwood
N B
NB
Gäken
J
J
Mohamedali
A
A
Cervera
J
J
Germing
U
U
Gattermann
N
N
Giagounidis
A
A
Garcia-Casado
Z
Z
Sanz
G
G
Mufti
G J
GJ
D000368:Aged; D000369:Aged, 80 and over; D000753:Anemia, Refractory / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D000756:Anemia, Sideroblastic / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015994:Incidence; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D017354:Point Mutation
C507924:JAK2 protein, human; D053614:Janus Kinase 2